LinkedIn·Friday, 31 July 2026·26d ago
This announcement is so cool that I decided to make a little flag 🏁 ImmuneWatch is partnering up with QIAGEN to bring free TCR sequencing…
Sander Wuyts
Extract real value out of TCR repertoires | 🔎 CEO ImmuneWatch
This announcement is so cool that I decided to make a little flag 🏁
ImmuneWatch is partnering up with QIAGEN to bring free TCR sequencing and Analysis to you!
Working in industry or academia and want to dig deeper into the T-cell response in your samples? This grant is for you.
Winners get:
🧬 Free QIAGEN RNA extraction + Bulk-TCR-seq library prep kit
🔬 Free sequencing, performed by QIAGEN
📊 Full data analysis by ImmuneWatch from TCR clonotype clustering to antigen annotations
4 spots total (2 academia, 2 industry). Applications are open now:
https://lnkd.in/ecH4SBTi
If that's not worth a self-designed flag, I don't know what is 🤣
💬 13↻ 3
View on LinkedIn Cross-referenced
Related on the wire
Last week was a fun week here on LinkedIn 😃
Building a spin-off out of a university lab usually brings a lot of deep scientific knowledge to the table but just a thin layer of…
When I started ImmuneWatch, I was still very much a researcher. Head down in the analysis. Trying to make the technology better, adding…
I'll be honest: When I started my own AI x biology company this was not on my "expectations list" QIAGEN put us on their homepage (!) to…
There's so much stuff hiding in your PBMCs! But you need to read it out properly: what's my T-cell diversity, are they expanding, what are…
We're working on something new: The ImmuneWatch Analyser Ideal for those doing immunomonitoring with TCR repertoires. The idea of this…